Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health

Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation(Nasdaq: PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million, subject to customary closing adjustments. This transaction is expected to be complete in the second half of calendar year 2024.